BRADLEY WILLIAM NICHOLSON, M.D.

STUART, VA

Research Active
Surgery NPI registered 21+ years 50 publications 2020 – 2026 NPI: 1144227836
MiceNeoplasmsAntineoplastic AgentsTumor MicroenvironmentUnited KingdomEarly Detection of CancerQualitative ResearchPatient Reported Outcome MeasuresNeoplasm StagingStructure-Activity RelationshipEnzyme InhibitorsPrimary Health CarePredictive Value of TestsLegionella pneumophilaSOXB1 Transcription Factors

Practice Location

18877 JEB STUART HWY
STUART, VA 24171

Phone: (276) 694-4466

What does BRADLEY NICHOLSON research?

Dr. Nicholson studies various aspects of cancer, particularly how different cells in the body interact during cancer progression and treatment. His research involves understanding how immune cells, like macrophages and neutrophils, behave in cancer settings and how targeting these behaviors can improve immunotherapies. He also investigates how tools, such as AI, can support oncology nurses in symptom management, aiming to enhance the overall care for cancer patients. Additionally, he analyzes public perceptions and decision-making regarding cancer screening, which is vital for informing healthcare policies and practices.

Key findings

  • Dr. Nicholson discovered a new compound, DFMP, that effectively inhibits proteins linked to cancer, significantly increasing immune response activation in mice.
  • In a study of 1,018 participants, about two-thirds were willing to accept screening downsides for the chance to reduce cancer deaths.
  • 67% of oncology nurses believe that AI models could improve symptom management, while 86% think these models could lead to earlier detection of serious symptoms.

Frequently asked questions

Does Dr. Nicholson study cancer treatments?
Yes, he focuses on the interaction between immune cells and cancer, aiming to enhance treatment effectiveness.
What is the importance of AI in Dr. Nicholson's research?
He evaluates how AI can assist oncology nurses in managing patient symptoms, potentially leading to better care outcomes.
Is Dr. Nicholson's work relevant to patients undergoing screening for cancer?
Absolutely, his research on public perceptions about cancer screening helps shape how screening programs are developed.
How does Dr. Nicholson's research impact women with breast cancer?
He is involved in studies aimed at improving adherence to hormone therapy, which is crucial for women with early-stage breast cancer.
What findings does Dr. Nicholson have regarding cancer screening?
His studies show that many people prioritize the benefits of cancer screening, such as saving lives, over the potential harms.

Publications in plain English

Role of overdiagnosis in the rising incidence of endometrial cancer: a population-based ecological study.

2026

BMJ evidence-based medicine

Barmayehvar B, Behzadnia A, Nicholson B, Zahl PH, Oke J

Plain English
This study looked at the rising number of endometrial cancer cases in Norway from 1970 to 2019, finding that overall diagnoses increased by 79%, especially among postmenopausal women, where early-stage cases climbed by 73% and late-stage cases by 108%. Despite more diagnoses, deaths from this cancer have remained stable, which suggests that many detected cases might not have been life-threatening, a phenomenon known as overdiagnosis. Understanding these trends is crucial for improving cancer detection and treatment practices. Who this helps: This information is important for patients, doctors, and healthcare policymakers.

PubMed

Perception of AI Symptom Models in Oncology Nursing: Mixed Methods Evaluation Study.

2026

JMIR nursing

Nicholson B, Sloss EA, Smiley A, Finkelstein J, Mooney K

Plain English
This study looked at how oncology nurses feel about using artificial intelligence (AI) models to predict and manage symptoms in cancer patients. The findings showed that most nurses (67%) believe an AI model could improve symptom management and 86% think it would help catch serious symptoms early. Nurses also emphasized the importance of understanding how the AI works and being involved in its development before it can be widely adopted. Who this helps: This helps patients undergoing cancer treatment by potentially improving their symptom management and care.

PubMed

Public (un)willingness to trade-off benefits and harms in decisions about cancer screening: A discrete choice experiment.

2026

Journal of medical screening

Dennison RA, Wright S, Lyratzopoulos G, Pashayan N, Morris S +3 more

Plain English
This study looked at how willing people are to accept certain downsides of cancer screening, like false alarms or unnecessary diagnoses, in exchange for its benefits, such as preventing cancer deaths. Out of 1,018 participants, most (about two-thirds) were likely to choose screening if it meant reducing deaths from cancer, even if there were some associated harms. This is important because it shows that public preference is more focused on the chance to save lives rather than the risks involved, which could help shape future cancer screening programs. Who this helps: This helps patients and public health officials in making informed decisions about cancer screening options.

PubMed

Comparative single cell analysis of wound and cancer identifies the metabolic dialogues between tumor initiating stem cells and macrophages.

2026

bioRxiv : the preprint server for biology

Guo W, Leon D, Nicholson B, Que J, Miao Y

Plain English
This study examined how certain immune cells, called macrophages, behave differently during skin healing compared to cancer growth. Researchers found that in cancer, these macrophages have altered fat metabolism, which is influenced by stem cells that help start tumors. Targeting the interactions between these stem cells and macrophages could improve cancer treatments. Who this helps: This benefits cancer patients by potentially improving treatment effectiveness.

PubMed

Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors.

2026

Journal of medicinal chemistry

Zheng XM, Candito DA, Jewell J, Childers M, Kawamura S +47 more

Plain English
This research focused on a new compound called DFMP that inhibits two important proteins, PTPN1 and PTPN2, which are linked to cancer treatment. The study found that DFMP is very effective at blocking these proteins, with improved potency and selectivity; it showed a strong effect in mice, leading to increased activation of important immune responses. This discovery is important because it may enhance cancer therapies by better targeting immune system pathways. Who this helps: Cancer patients who may benefit from improved immuno-oncology treatments.

PubMed

Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche.

2026

Cancer cell

Guo W, Luan J, Huang X, Leon D, Gang S +15 more

Plain English
Researchers studied how certain cancer stem cells influence the behavior of immune cells called neutrophils within tumors. They found that tumor-initiating stem cells can create a protective environment that helps survive cancer treatments, by blocking neutrophils from effectively fighting cancer. This is important because it highlights a mechanism that allows cancer to persist and potentially return, showing the need for more effective therapies. Who this helps: This helps doctors and researchers looking to improve cancer treatments.

PubMed

Digital Patient-Reported Cancer Symptom Management: Comparison of Black and White Participants.

2025

Cancer medicine

Gullatte M, Nicholson B, Sloss E, Alekhina N, Marie Moraitis A +3 more

Plain English
This study looked at how well a digital system for reporting cancer symptoms worked for Black and White patients undergoing chemotherapy. It found that while both groups experienced a decrease in symptoms and were generally satisfied with the system, Black patients reported their symptoms less consistently than White patients (65% vs. 73%). This matters because it shows that digital tools can effectively help manage symptoms for all patients, but highlights the need for extra support to ensure Black patients engage fully with these tools. Who this helps: This helps cancer patients, especially those who are Black, by improving their symptom management experience.

PubMed

Step count and symptom severity during cancer treatment using the Symptom Care at Home digital platform.

2025

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Nicholson B, Moraitis AM, Cawley K, Wong B, Echeverria C +1 more

Plain English
This study looked at cancer patients during treatment and how their symptoms, like fatigue and nausea, affected the number of steps they took each day using a digital monitoring tool. They found that on average, patients took about 3,164 steps a day, but for every one-point increase in symptom severity, daily steps dropped by about 46. This is important because it highlights how much cancer symptoms can limit activity levels, especially fatigue, suggesting that tracking both symptoms and physical activity could improve patient care and response. Who this helps: This helps cancer patients and their doctors understand the impact of symptoms on physical activity.

PubMed

A bacterial toxin-antitoxin system involved in an unusual response to genotoxic stress.

2025

EMBO reports

Lin JD, Nicholson B, Ensminger AW

Plain English
This study looked at how a specific bacterial strain, Legionella pneumophila, responds to stressful conditions, particularly those that damage its DNA. Researchers found that a toxin-antitoxin system called GndRX actually leads to cell death under certain stress, while bacteria lacking this system survive better in tough conditions. This discovery highlights a new way bacteria can endure tough times, which is important for understanding infections and developing treatments. Who this helps: This helps doctors and researchers working on bacterial infections.

PubMed

The discovery of aphage explains a key determinant of human disease.

2025

Science advances

Nicholson B, Santé JF, Chaney EH, Deme JC, Deecker SR +4 more

Plain English
This study focused on a newly discovered virus called bacteriophage LME-1, which can kill bacteria that cause diseases in humans. Researchers found that this phage has a unique structure and identified its ability to target bacterial strains responsible for 80% of Legionnaires' disease, a serious lung infection. Understanding how this phage works is important because it could lead to new treatments that help fight these harmful bacteria in patients. Who this helps: Patients suffering from Legionnaires' disease.

PubMed

Pyomo: Accidentally outrunning the bear.

2025

Patterns (New York, N.Y.)

Mundt M, Hart WE, Johnson ES, Nicholson B, Siirola JD

Plain English
This paper discusses the development of Pyomo, an open-source software used for optimization modeling. Since its start in 2008, it has become more flexible and improved in how it works with other software, thanks to better collaboration tools. The Pyomo team has faced challenges, like limited resources and keeping knowledge within the community, but their commitment to improvement shows how they aim to help other open-source projects learn from their journey. Who this helps: This benefits software developers and researchers using open-source tools for optimization.

PubMed

Interplay of geometry and magnetic coupling in ferromagnetic nanorings.

2025

Nanoscale

Oramus SP, de Rojas J, Scott JR, Nicholson B, Atkinson D +1 more

Plain English
This study looked at how the shape and arrangement of small magnetic rings made of nickel and iron affect their magnetic behavior. Researchers found that the distance between the rings influenced how easily they switched magnetic states, with closer rings showing stronger interactions. Specifically, the magnetic behavior was notably different based on their shape and the angle of the magnetic field applied, revealing new ways to enhance their performance for future technologies like brain-inspired computing. Who this helps: This benefits researchers and developers working on advanced computing technologies.

PubMed

Use of the BIOFIREFILMARRAYPneumonia plus Panel to characterize the etiology of lower respiratory tract infections among hospitalized patients in Southern Province, Sri Lanka.

2025

BMC infectious diseases

Weishampel ZA, Nagahawatte A, Wijayaratne G, Wickramasinghe SS, Nicholson B +14 more

Plain English
In this study, researchers looked at the causes of lower respiratory infections in hospitalized patients in southern Sri Lanka using a special test on sputum samples to identify bacteria and viruses. They found that out of 267 patients, the most common bacteria were Klebsiella pneumoniae (41.9%), Staphylococcus aureus (34.5%), and Acinetobacter species (32.6%), while 79% had at least one strain of harmful gram-negative bacteria. This matters because it highlights a significant presence of harmful bacteria and antibiotic resistance, making treatment more complex and underscoring the need for better diagnostic tools. Who this helps: This helps doctors and healthcare providers in treating patients with respiratory infections.

PubMed

Cost-Effective Components of a Patient-Reported Symptom Monitoring System for Chemotherapy.

2025

JAMA network open

Mooney K, Yoo M, Sloss ES, Nicholson B, Alekhina NS +2 more

Plain English
This study looked at different ways to help cancer patients manage their symptoms while undergoing chemotherapy using an electronic reporting system. Researchers found that a complete symptom management program, which included follow-up from nurses and decision support, cost about $14,590 over six months—and this combination was the most cost-effective option when compared to other methods. This matters because it shows that using a comprehensive system not only helps reduce the severity of symptoms but also provides good value for healthcare spending. Who this helps: This helps cancer patients and healthcare providers by improving care while managing costs.

PubMed

Evaluating a Clinical Decision Support Tool for Cancer Risk Assessment in Primary Care: Simulation Study of Unintended Weight Loss.

2025

JMIR formative research

Martinez-Gutierrez J, Chima S, De Mendonca L, Lee A, Hunter B +9 more

Plain English
This study looked at a tool designed to help doctors identify patients at risk of undiagnosed cancer based on unintended weight loss. Researchers found that doctors responded positively to the tool, using it to aid conversations with patients and to remind them of important follow-up actions, although its impact on communication varied among different doctors. This is important because improving early cancer detection could lead to better outcomes for patients. Who this helps: This helps doctors and patients by improving the chances of catching cancer early.

PubMed

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.

2025

Trials

McGeagh L, Walker A, Hiller L, Dunn J, Wells M +25 more

Plain English
The SWEET study is investigating how to help women with early-stage breast cancer stick to their prescribed hormone therapy, which is crucial for reducing the chances of their cancer returning and improving survival. The study involves 1,460 women and aims to compare the effects of a new support program called HT&Me against standard care. Early findings suggest that better adherence to this therapy can lead to improved quality of life and lower healthcare costs, making it significant for patient health and healthcare systems. Who this helps: This helps women diagnosed with early-stage breast cancer and their healthcare providers.

PubMed

The Benefit of Cost-Transparency Calculators Does Not Extend to Vascular Surgery Patients.

2024

Annals of vascular surgery

Tedesco A, Bloom JA, Lee J, Nicholson B, Moon T +4 more

Plain English
This study looked at how useful price transparency tools are for patients needing vascular surgery, following a mandate that hospitals provide these online cost calculators. Out of 50 top hospitals, only 10% provided price information for arteriovenous fistula surgery and 12% for varicose vein procedures, while none listed costs for endovascular aneurysm repair, making it hard for patients to prepare financially for their procedures. This lack of information means vascular surgery patients may struggle to find affordable care and make informed choices about where to have their surgeries. Who this helps: This benefits vascular surgery patients who need better access to cost information.

PubMed

XTX301, a Tumor-Activated Interleukin-12 Has the Potential to Widen the Therapeutic Index of IL12 Treatment for Solid Tumors as Evidenced by Preclinical Studies.

2024

Molecular cancer therapeutics

Patel E, Malkova NV, Crowe D, Pederzoli-Ribeil M, Fantini D +25 more

Plain English
This study focused on a new treatment called XTX301, which is designed to fight solid tumors without causing the severe side effects seen with existing IL12 therapies. Researchers found that XTX301 effectively reduced tumor growth in mouse models without harming other healthy tissues, showing a significant tumor growth inhibition in both inflamed and non-inflamed conditions. These findings suggest that XTX301 can boost the body's immune response specifically in tumors, making it a promising option for safer cancer treatment. Who this helps: This benefits cancer patients seeking effective therapies with fewer side effects.

PubMed

Diagnostic yield from symptomatic lower gastrointestinal endoscopy in the UK: A British Society of Gastroenterology analysis using data from the National Endoscopy Database.

2024

Alimentary pharmacology & therapeutics

Beaton D, Sharp L, Lu L, Trudgill N, Thoufeeq M +7 more

Plain English
This study looked at the effectiveness of lower gastrointestinal endoscopy (LGIE), which includes procedures like colonoscopy, in diagnosing conditions like cancer in patients with specific symptoms. Researchers analyzed data from over 384,000 LGIEs and found that the chance of finding cancer was only 1.5% overall, rising to 1.9% in patients over 50 and to 2.5% in those experiencing rectal bleeding. Most procedures were done on low-risk patients, and in those under 50, the chance of finding cancer was just 0.4%. Who this helps: This research helps doctors and patients by highlighting the need for appropriate use of endoscopy, especially in younger and lower-risk individuals.

PubMed

Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection.

2024

European urology open science

Maurer J, Eugster PJ, Collins K, Vocat C, Oke J +4 more

Plain English
This research looked at a chemical called neuropeptide Y (NPY) to see if it could help diagnose prostate cancer better than the standard test, which measures prostate-specific antigen (PSA). They studied blood samples from 181 men and found that NPY was less accurate for detecting significant prostate cancer compared to PSA. While NPY might have some value for patients with PSA levels between 4 and 9 ng/ml, overall, it didn't improve diagnosis, meaning it's not ready to be used alongside or instead of PSA tests. Who this helps: This study helps doctors and researchers understand that NPY is not a reliable tool for diagnosing prostate cancer and reinforces the use of PSA testing.

PubMed

Assessing Patient Perspectives and the Health Equity of a Digital Cancer Symptom Remote Monitoring and Management System.

2024

JCO clinical cancer informatics

Mooney K, Beck SL, Wilson C, Coombs L, Whisenant M +8 more

Plain English
The study looked at a digital system called Symptom Care at Home (SCH) designed to help cancer patients manage their symptoms remotely while receiving treatment. Out of 358 participants, those using SCH reported a significant reduction in symptoms, with non-White and lower-income individuals experiencing even greater improvements compared to their peers. On average, daily adherence to reporting symptoms was 90%, and satisfaction with the system was high, indicating that digital tools can help bridge care gaps and improve outcomes for diverse patient groups. Who this helps: This helps cancer patients, especially those who are non-White or have lower incomes, by providing them with better symptom management options.

PubMed

A scoping review of unexpected weight loss and cancer: risk, guidelines, and recommendations for follow-up in primary care.

2024

BJGP open

Martinez-Gutierrez J, De Mendonca L, Ly P, Lee A, Hunter B +9 more

Plain English
This study looked at unexpected weight loss (UWL) as a possible early sign of cancer by reviewing 25 research studies involving over 916,000 patients. It found that 92% of the studies linked UWL to undiagnosed cancer and highlighted the need for clearer guidelines on how doctors should assess patients who present with this symptom. Understanding UWL is crucial because it could help doctors detect cancer earlier, improving patient outcomes. Who this helps: This helps patients and their doctors by providing better methods for identifying potential cancer cases earlier.

PubMed

Predictive value of abnormal blood tests for detecting cancer in primary care patients with nonspecific abdominal symptoms: A population-based cohort study of 477,870 patients in England.

2024

PLoS medicine

Rafiq M, Renzi C, White B, Zakkak N, Nicholson B +2 more

Plain English
This study looked at how effective abnormal blood tests are at detecting cancer in patients who report vague abdominal symptoms, like pain or bloating. Researchers analyzed health data from nearly 478,000 patients and found that about 2.2% of those with these symptoms were diagnosed with cancer within a year. They discovered that in older adults (60 and over), certain abnormal blood test results significantly raised the risk of having cancer, suggesting that doctors should consider these tests to improve early detection and timely referrals for further investigation. Who this helps: This helps patients with abdominal symptoms and their doctors by improving cancer detection strategies.

PubMed

Essential Components of an Electronic Patient-Reported Symptom Monitoring and Management System: A Randomized Clinical Trial.

2024

JAMA network open

Mooney K, Gullatte M, Iacob E, Alekhina N, Nicholson B +4 more

Plain English
This study looked at a digital system for managing symptoms in cancer patients undergoing chemotherapy. It found that patients who used the complete system—combining automated coaching and follow-up from a nurse practitioner—experienced significantly lower symptom severity compared to those using only parts of the system. Specifically, patients in the full program had a mean symptom burden reduction score of 2.38, which was much more effective than any individual approach. Who this helps: This research is beneficial for cancer patients and their healthcare providers.

PubMed

SOX2-driven enhancer landscape defines the transcriptional architecture of retinogenesis.

2024

Development (Cambridge, England)

Bian F, Golestaneh K, Davis E, Khan A, Nicholson B +6 more

Plain English
This study focused on understanding how a protein called SOX2 helps control the development of retinal cells from progenitor cells. Researchers found that SOX2 is crucial for activating certain genes necessary for making retinal cells, and when SOX2 is disrupted, it affects the growth and specialization of these cells. Specifically, when SOX2 was not functioning properly, there was a notable loss of activity near important genes related to retinal development. Who this helps: This research benefits patients with retinal diseases and conditions by improving our understanding of cell development, which could lead to better treatments.

PubMed

Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN Survey.

2023

Journal of clinical immunology

Israni M, Nicholson B, Mahlaoui N, Obici L, Rossi-Semerano L +21 more

Plain English
This study looked at how young people with immune system disorders in Europe transition from children's health services to adult care. Researchers found that most centers start the transition process around ages 16-18 and transfer patients by ages 18-20, with many facilities holding joint appointments between pediatric and adult services. Although 75% of centers reported having a transition process in place, very few have specific national guidelines to ensure best practices. Who this helps: This helps patients with immune disorders and their families as well as healthcare providers in preparing for effective care transitions.

PubMed

Recurrent activity in neuronal avalanches.

2023

Scientific reports

Salners T, Avila KE, Nicholson B, Myers CR, Beggs J +1 more

Plain English
This research studied how large bursts of brain activity, called neuronal avalanches, behave in mouse and rat brains. The researchers found that these large avalanches show repeated patterns of activity and can be understood using a model that describes how neurons become less responsive over time. Specifically, they observed that this model accurately matched the size and frequency of these larger bursts, indicating that changes in neuron activity are important for understanding big brain events, like seizures. Who this helps: This helps doctors and researchers studying brain activity and seizure disorders.

PubMed

Associations Between Motor Competence and Physical Activity, Physical Fitness and Psychosocial Characteristics in Adolescents: A Systematic Review and Meta-analysis.

2023

Sports medicine (Auckland, N.Z.)

Burton AM, Cowburn I, Thompson F, Eisenmann JC, Nicholson B +1 more

Plain English
This study looked at how motor skills in teenagers relate to their physical activities, fitness levels, and social-emotional traits. Researchers analyzed 61 studies involving over 22,000 adolescents and found that better motor skills were linked to more physical activity (with a correlation ranging from 0.20 to 0.26) and positive psychosocial traits (correlation from 0.07 to 0.34), whereas lower motor skills were associated with poorer weight status and reduced speed and agility. Understanding these connections is important because improving motor competence could lead to healthier lifestyles and better mental well-being for teenagers. Who this helps: Teens aiming to live healthier lives, as well as the adults supporting their development.

PubMed

Temporal dynamics of normalization reweighting.

2023

Journal of vision

Baker DH, Marinova D, Aveyard R, Hargreaves LJ, Renton A +8 more

Plain English
This study looked at how the brain suppresses visual information and how that suppression changes over time when we see the same pairs of images repeatedly. Researchers found that this suppression increases significantly within the first 2 to 5 seconds of seeing the images together. Importantly, the study demonstrated that people with high autistic traits did not show significant differences in this visual suppression process compared to those with low traits or no autism diagnosis. Who this helps: This research benefits scientists and clinicians studying visual processing, especially in relation to autism.

PubMed

Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance.

2023

Scientific reports

Ko ER, Reller ME, Tillekeratne LG, Bodinayake CK, Miller C +26 more

Plain English
This study looked at how well gene expression can tell the difference between bacterial and viral infections in people with fever. Researchers collected data from 294 participants and developed a model that correctly identified bacterial infections from viral ones 93% of the time. When tested again with a new group of 101 people, the model still showed strong performance with 81.6% accuracy, proving it works well regardless of age or location. Who this helps: This helps doctors provide better diagnoses for patients with fevers, leading to more appropriate treatments.

PubMed

XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.

2023

Journal for immunotherapy of cancer

Jenkins KA, Park M, Pederzoli-Ribeil M, Eskiocak U, Johnson P +14 more

Plain English
Researchers studied a new drug called XTX101, designed to target and fight cancer tumors while reducing side effects often seen with other treatments. They found that XTX101 significantly slowed tumor growth in mice, leading to complete tumor responses in some cases, and it worked well both alone and with other therapies; specifically, it increased the presence of immune cells that attack tumors while leaving healthy tissue largely unaffected. This is important because it could mean fewer side effects and a more effective treatment option for patients with different types of cancer. Who this helps: Patients with various cancers, including melanoma and lung cancer.

PubMed

The Training of Medium- to Long-Distance Sprint Performance in Football Code Athletes: A Systematic Review and Meta-analysis.

2022

Sports medicine (Auckland, N.Z.)

Nicholson B, Dinsdale A, Jones B, Till K

Plain English
This study looked at how different training methods can improve medium- and long-distance sprinting for football players. The researchers analyzed 60 studies involving 1,500 athletes, finding that combined, secondary, and tertiary training methods led to noticeable improvements in sprinting performance. Specifically, athletes showed moderate improvements in their sprint times and maximum sprinting speed, especially with tertiary methods. Who this helps: This research benefits football players looking to enhance their sprinting abilities.

PubMed

Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.

2022

Blood cancer discovery

Ibarra J, Elbanna YA, Kurylowicz K, Ciboddo M, Greenbaum HS +23 more

Plain English
This study examined differences between two types of mutations in the calreticulin gene that are linked to myeloproliferative neoplasms (MPNs), a type of blood cancer. Researchers found that type I mutations lead to a shutdown of a cellular process that helps manage stress, which makes the cancer cells dependent on a specific pathway (IRE1α/XBP1) for survival. Targeting this pathway could help stop the disease's progression in patients with type I mutations, while existing therapies do not effectively differentiate between the mutation types. Who this helps: This research helps patients with type I calreticulin mutations.

PubMed

Current and projected number of years of life lost due to prostate cancer: A global study.

2022

The Prostate

Withrow D, Pilleron S, Nikita N, Ferlay J, Sharma S +3 more

Plain English
This study looked at how many years of life are lost due to prostate cancer around the world. In 2020, there were 3.5 million years of life lost from prostate cancer in men over 50, with 40% of those losses occurring in men over 75. By 2040, this number is expected to double to 7.5 million, especially increasing in Africa, Asia, and Latin America, highlighting a growing global health issue that needs attention. Who this helps: This information benefits public health officials and researchers focused on cancer prevention and treatment strategies.

PubMed

Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood.

2022

Journal of clinical immunology

Day JW, Elfeky R, Nicholson B, Goodman R, Pearce R +16 more

Plain English
This study examined the long-term health of 83 adults who underwent a specific type of stem cell transplant as children to treat immune disorders. It found that 51% of these patients remained free from serious health issues 20 years after their transplant, but many still faced ongoing medical problems, including chronic infections and autoimmune diseases. Addressing certain conditions early on could improve their overall health in adulthood. Who this helps: This helps patients who underwent stem cell transplants for immune disorders in childhood.

PubMed

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity.

2022

Journal of clinical immunology

Nicholson B, Goodman R, Day J, Worth A, Carpenter B +6 more

Plain English
This study looked at adults who had a type of stem cell transplant as children to treat immune system disorders. Researchers found that while these adults reported better physical health compared to the general population, their mood was worse, and they experienced more anxiety than average. This is important because it shows that even though the transplant can improve physical health, it may not address emotional and social well-being, indicating a need for ongoing support. Who this helps: This helps patients who underwent stem cell transplants in childhood and their families.

PubMed

Levelling up prevention in primary care.

2022

BMJ (Clinical research ed.)

Heath L, Nicholson B, Aveyard P

PubMed

A Randomized Comparison of Clothing Removal Techniques in a Simulated Trauma Patient Exposure.

2022

Cureus

Cummings C, Sibley A, Jain T, Nicholson B

Plain English
This study tested different tools for removing clothing from trauma patients to see which one works best. It found that the S-Cut QE cut clothes off faster than two other methods, with an average time of just 78 seconds compared to 142 seconds for trauma shears and 209 seconds for the other knife. This is important because faster clothing removal can help emergency responders quickly assess and treat injuries. Who this helps: This helps patients in emergency situations by enabling faster medical assessments.

PubMed

Mobile Element Integration Reveals a Chromosome Dimer Resolution System in.

2022

mBio

Nicholson B, Deecker SR, Ensminger AW

Plain English
This study focused on a bacteria called Legionella pneumophila, which can cause severe infections in humans. Researchers found a new system in this bacteria that helps fix problems with its DNA during cell division. Specifically, they discovered a unique recombinase that resolves chromosome dimers – a situation that could cause cell growth issues – and showed that this system is also present in another harmful bacteria, Coxiella burnetii. This is important because understanding how these bacteria maintain their DNA stability could lead to better treatments for infections they cause. Who this helps: This helps doctors and researchers working to develop treatments for bacterial infections.

PubMed

Authors' Reply to Wewege et al.: Comment on: "The training of short distance sprint performance in football code athletes: a systematic review and meta-analysis".

2021

Sports medicine (Auckland, N.Z.)

Nicholson B, Dinsdale A, Jones B, Till K

PubMed

The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.

2021

Journal of medicinal chemistry

Quiroz RV, Reutershan MH, Schneider SE, Sloman D, Lacey BM +32 more

Plain English
Researchers developed two new types of drugs that target a specific protein called PRMT5, which is linked to many cancers. Their testing showed these drugs are effective at low doses and can work well in the body. This matters because it could lead to new treatments for patients with various types of cancer who might not have many options. Who this helps: This helps cancer patients seeking new treatment options.

PubMed

Governance of community health worker programs in a decentralized health system: a qualitative study in the Philippines.

2021

BMC health services research

Dodd W, Kipp A, Nicholson B, Lau LL, Little M +2 more

Plain English
This study looked at how community health worker (CHW) programs operate in different parts of the Philippines, particularly in relation to local governance and resource allocation. Researchers conducted 85 interviews with CHWs and their administrators and found that CHW programs varied widely in quality and effectiveness due to differences in funding and training based on local political conditions. Improving support and resources for CHWs can help them better serve their communities and contribute to overall health care goals. Who this helps: This helps community health workers and the patients they serve.

PubMed

The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.

2021

The Journal of infection

Zarif A, Joy M, Sherlock J, Sheppard JP, Byford R +14 more

Plain English
This study looked at the effects of a government recommendation for vulnerable individuals aged 40 and older in the UK to self-isolate, or "shield," for 12 weeks during the COVID-19 pandemic. It found that during the first 21 days of shielding, these individuals had half the risk of dying compared to those who were not advised to shield (a hazard ratio of 0.50). However, the risks changed dramatically after the initial period; after 21 days, those who shielded had a 54% higher risk of dying during the rest of the shielding period and over two-and-a-half times higher risk after shielding ended. Who this helps: This benefits vulnerable patients and their healthcare providers.

PubMed

Legionella pneumophila CRISPR-Cas Suggests Recurrent Encounters with One or More Phages in the Family.

2021

Applied and environmental microbiology

Deecker SR, Urbanus ML, Nicholson B, Ensminger AW

Plain English
This research studied how the bacteria Legionella pneumophila, which causes Legionnaires' disease, interacts with viruses called phages. The researchers analyzed over 600 bacteria samples and identified 150 CRISPR-Cas systems that help these bacteria defend themselves against certain threats. They found that while most known phages were not attacking L. pneumophila, some of the bacteria's defense sequences matched known microviruses, suggesting L. pneumophila regularly encounters these viruses. Who this helps: This information can benefit scientists studying bacterial diseases and developing new treatments.

PubMed

Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.

2021

BMC infectious diseases

Trombetta BA, Kandigian SE, Kitchen RR, Grauwet K, Webb PK +53 more

Plain English
This study looked at different tests that can detect antibodies for COVID-19 (SARS-CoV-2) to see how accurate they are. Out of 20 tests evaluated, the most effective test, Lumiquick, identified about 98.2% of positive cases, while other tests showed sensitivity between 33.9% and 94.6%. This is important because it helps ensure people can accurately know if they have been exposed to the virus, which is crucial for managing disease spread and vaccinations. Who this helps: This helps patients and healthcare providers by improving testing accuracy for COVID-19 antibodies.

PubMed

Sprint and Jump Mechanical Profiles in Academy Rugby League Players: Positional Differences and the Associations between Profiles and Sprint Performance.

2021

Sports (Basel, Switzerland)

Nicholson B, Dinsdale A, Jones B, Till K

Plain English
This study looked at how male academy rugby league players sprint and jump, focusing on differences between players in different positions and how their mechanics relate to speed. Researchers tested 20 players with sprints and jump exercises while measuring their strength and power. They found that forwards were more powerful but could jump lower and sprint slower than backs; specifically, forward players showed up to 77% higher in specific force measurements related to quick sprints. Who this helps: This research benefits coaches and trainers working with rugby players, helping them tailor training programs to improve performance based on player positions.

PubMed

Correction to: Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2.

2021

BMC infectious diseases

Trombetta BA, Kandigian SE, Kitchen RR, Grauwet K, Webb PK +53 more

PubMed

Advanced care planning: The concept over time.

2021

Nursing forum

Nicholson B

Plain English
This study looked at how advanced care planning (ACP) has evolved over time, focusing on its importance for end-of-life decisions. Researchers reviewed 187 articles to track its transition from a legal idea to a key topic in healthcare. They emphasized that better understanding of ACP can help nurses communicate effectively with patients and families about these crucial conversations. Who this helps: This helps patients, families, and healthcare providers by improving end-of-life care discussions.

PubMed

Physical Preparation in Female Rugby Codes: An Investigation of Current Practices.

2020

Frontiers in sports and active living

Heyward O, Nicholson B, Emmonds S, Roe G, Jones B

Plain English
This study looked at how female rugby teams prepare physically for their sport. Researchers surveyed 37 coaches and trainers, finding that most focus on performance testing during the season (97%) and use various training methods like resistance and cardiovascular exercises (over 89%). It’s important because it highlights the need for targeted preparation strategies for female athletes, who may have different physical and psychological needs compared to males. Who this helps: This helps coaches and trainers working with female rugby players.

PubMed

Electronic cigarettes as a smoking cessation aid for patients with cancer: beliefs and behaviours of clinicians in the UK.

2020

BMJ open

Brett J, Davies EL, Matley F, Aveyard P, Wells M +6 more

Plain English
This study looked at the views and practices of UK doctors who treat cancer patients regarding the use of e-cigarettes to help quit smoking. The findings showed that 29% of these doctors do not recommend e-cigarettes to patients who continue to smoke. Factors that influenced their willingness to recommend e-cigarettes included their knowledge about smoking cessation and e-cigarettes, their beliefs in their effectiveness, and their comfort discussing them with patients. Who this helps: This helps cancer patients who smoke and are looking for support to quit.

PubMed

Frequent Co-Authors

Kathi Mooney Eli Iacob Alexander W Ensminger Ann Marie Moraitis Kevin Till Ben Jones Elizabeth A Sloss Jason Oke Shayna R Deecker

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.